1
|
Lion T, Haas OA, Harbott J, Bannier E,
Ritterbach J, Jankovic M, Fink FM, Stojimirovic A, Herrmann J,
Riehm HJ, et al: The translocation t(1;22)(p13;q13) is a nonrandom
marker specifically associated with acute megakaryocytic leukemia
in young children. Blood. 79:3325–3330. 1992.PubMed/NCBI
|
2
|
Athale UH, Razzouk BI, Raimondi SC, Long
X, Behm FG, Head DR, Srivastava DK, Rubnitz JE, Bowman L, Pui CH
and Ribeiro RC: Biology and outcome of childhood acute
megakaryoblastic leukemia: A single institution's experience.
Blood. 97:3727–3732. 2001.PubMed/NCBI View Article : Google Scholar
|
3
|
Dastugue N, Lafage-Pochitaloff M, Pagès
MP, Radford I, Bastard C, Talmant P, Mozziconacci MJ, Léonard C,
Bilhou-Nabéra C, Cabrol C, et al: Cytogenetic profile of childhood
and adult megakaryoblastic leukemia (M7): A study of the Groupe
Français de Cytogénétique Hématologique (GFCH). Blood. 100:618–626.
2002.PubMed/NCBI View Article : Google Scholar
|
4
|
Reinhardt D, Diekamp S, Langebrake C,
Ritter J, Stary J, Dworzak M, Schrauder A, Zimmermann M,
Fleischhack G, Ludwig WD, et al: Acute megakaryoblastic leukemia in
children and adolescents, excluding Down's syndrome: Improved
outcome with intensified induction treatment. Leukemia.
19:1495–1496. 2005.PubMed/NCBI View Article : Google Scholar
|
5
|
Carroll A, Civin C, Schneider N, Dahl G,
Pappo A, Bowman P, Emami A, Gross S, Alvarado C, Phillips C, et al:
The t(1;22) (p13;q13) is nonrandom and restricted to infants with
acute megakaryoblastic leukemia: A pediatric oncology group study.
Blood. 78:748–752. 1991.PubMed/NCBI
|
6
|
Bernstein J, Dastugue N, Haas OA, Harbott
J, Heere NA, Huret JL, Landman-Parker J, Lebeau MM, Leonard C, Mann
G, et al: Nineteen cases of the t(1;22)(p13;q13) acute
megakaryblastic leukaemia of infants/children and a review of 39
cases: Report from a t(1;22) study group. Leukemia. 14:216–218.
2000.PubMed/NCBI View Article : Google Scholar
|
7
|
Inaba H, Zhou Y, Abla O, Adachi S,
Auvrignon A, Beverloo HB, De Bont E, Chang TT, Creutzig U, Dworzak
M, et al: Heterogeneous cytogenetic subgroups and outcomes in
childhood acute megakaryoblastic leukemia: A retrospective
international study. Blood. 126:1575–1584. 2015.PubMed/NCBI View Article : Google Scholar
|
8
|
Ma Z, Morris SW, Valentine V, Li M,
Herbrick JA, Cui X, Bouman D, Li Y, Mehta PK, Nizetic D, et al:
Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13)
of acute megakaryoblastic leukemia. Nat Genet. 28:220–221.
2001.PubMed/NCBI View
Article : Google Scholar
|
9
|
Schweitzer J, Zimmermann M, Rasche M, Von
Neuhoff C, Creutzig U, Dworzak M, Reinhardt D and Klusmann JH:
Improved outcome of pediatric patients with acute megakaryoblastic
leukemia in the AML-BFM 04 trial. Ann Hematol. 94:1327–1336.
2015.PubMed/NCBI View Article : Google Scholar
|
10
|
de Rooij JD, Branstetter C, Ma J, Li Y,
Walsh MP, Cheng J, Obulkasim A, Dang J, Easton J, Verboon LJ, et
al: Pediatric non-down syndrome acute megakaryoblastic leukemia is
characterized by distinct genomic subsets with varying outcomes.
Nat Genet. 49:451–456. 2017.PubMed/NCBI View
Article : Google Scholar
|
11
|
Gröschel S, Lugthart S, Schlenk RF, Valk
PJ, Eiwen K, Goudswaard C, van Putten WJ, Kayser S, Verdonck LF,
Lübbert M, et al: High EVI1 expression predicts outcome in younger
adult patients with acute myeloid leukemia and is associated with
distinct cytogenetic abnormalities. J Clin Oncol. 28:2101–2107.
2010.PubMed/NCBI View Article : Google Scholar
|
12
|
Torres L, Lisboa S, Vieira J, Cerveira N,
Santos J, Pinheiro M, Correia C, Bizarro S, Almeida M and Teixeira
MR: Acute megakaryoblastic leukemia with a four-way variant
translocation originating the RBM15-MKL1 fusion gene. Pediatr Blood
Cancer. 56:846–849. 2011.PubMed/NCBI View Article : Google Scholar
|
13
|
Masetti R, Guidi V, Ronchini L, Bertuccio
NS, Locatelli F and Pession A: The changing scenario of non-down
syndrome acute megakaryoblastic leukemia in children. Crit Rev
Oncol Hematol. 138:132–138. 2019.PubMed/NCBI View Article : Google Scholar
|
14
|
Margolskee E, Saab J, Geyer JT, Aledo A
and Mathew S: A novel variant t(1;22)
translocation-ins(22;1)(q13;p13p31)-in a child with acute
megakaryoblastic leukemia. Am J Case Rep. 18:422–426.
2017.PubMed/NCBI View Article : Google Scholar
|
15
|
Gökçe M, Aytaç S, Ünal Ş, Altan İ, Gümrük
F and Çetin M: Acute megakaryoblastic leukemia with t(1;22)
mimicking neuroblastoma in an infant. Turk J Haematol. 32:64–67.
2015.PubMed/NCBI View Article : Google Scholar
|
16
|
Kawasaki Y, Makimoto M, Nomura K, Hoshino
A, Hamashima T, Hiwatari M, Nakazawa A, Takita J, Yoshida T and
Kanegane H: Neonatal acute megakaryoblastic leukemia mimicking
congenital neuroblastoma. Clin Case Rep. 3:145–149. 2015.PubMed/NCBI View
Article : Google Scholar
|
17
|
Marques-Piubelli ML, Cordeiro MG,
Cristofani L, Barroso RS, Paes VR, Castelli JB and Rodrigues
Pereira Velloso ED: Acute megakaryoblastic leukemia with
t(1;22)(p13.3;q13.1); RBM15-MKL1 mimicking hepatoblastoma in an
infant: The role of karyotype in differential diagnosis. Pediatr
Blood Cancer. 67(e28111)2020.PubMed/NCBI View Article : Google Scholar
|
18
|
Mercher T, Coniat MB, Monni R, Mauchauffe
M, Nguyen Khac F, Gressin L, Mugneret F, Leblanc T, Dastugue N,
Berger R and Bernard OA: Involvement of a human gene related to the
Drosophila spen gene in the recurrent t(1;22) translocation
of acute megakaryocytic leukemia. Proc Natl Acad Sci USA.
98:5776–5779. 2001.PubMed/NCBI View Article : Google Scholar
|